Ozempic and Pregnancy: What Expecting Mothers Need to Know

Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a GLP-1 receptor agonist used for weight management, has shown remarkable effectiveness in clinical trials—but pregnancy requires special medical consideration. If you're planning to become pregnant or recently discovered you're expecting, understanding how semaglutide affects fetal development is essential for making informed health decisions.

Semaglutide Safety During Pregnancy: Current Evidence

Animal reproduction studies on semaglutide have revealed fetal abnormalities in rats and rabbits when given at doses above those used in humans, according to regulatory reviews. The medication crosses the placental barrier, meaning it reaches the developing fetus. Because human pregnancy studies are limited and ethical constraints prevent controlled trials on pregnant women, regulatory agencies classify semaglutide as a Category C medication—meaning human data is insufficient and animal data shows some risk.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

When to Stop Semaglutide if You're Planning Pregnancy

Medical guidelines suggest stopping semaglutide at least two months before attempting conception, though some providers recommend earlier discontinuation depending on individual circumstances. This timeline allows your body to metabolize and clear the medication and gives your healthcare team time to establish baseline metabolic markers before pregnancy. Abrupt discontinuation typically does not cause dangerous rebound effects, though some patients experience gradual weight regain.

If you discover you're pregnant while taking semaglutide, do not panic—stopping immediately is the recommended action, but one or two doses during early pregnancy are unlikely to cause harm based on available data. Contact your obstetrical care provider and pharmacist right away to discuss your specific situation and create a revised health plan. Your pregnancy and your baby's health are the priority, and healthcare providers can monitor your progress with appropriate prenatal care.

Weight Management Before and After Pregnancy

Maintaining a healthy weight before pregnancy improves maternal and fetal outcomes, reducing risks of gestational diabetes, preeclampsia, and cesarean delivery. Weight loss through diet, exercise, and behavioral changes is the safest approach before conception if you're currently taking semaglutide. Consulting with an obstetrician and a registered dietitian can help you establish realistic targets and evidence-based strategies during this critical window.

After pregnancy and breastfeeding are complete, semaglutide may be reintroduced if medically appropriate and if weight regain becomes a health concern. The timing depends on your individual recovery, breastfeeding duration, and ongoing metabolic health. PlexusDx can support your personalized weight management plan once you and your healthcare provider have determined it is safe to resume therapy.

Postpartum Weight Loss and GLP-1 Therapy Options

Many women experience postpartum weight retention, and the period after breastfeeding concludes represents a potential window for reintroducing semaglutide if appropriate. PlexusDx Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) and does not require insurance, making it accessible during a time when family budgets are often strained. Your dose may need to go up—your price won't, following PlexusDx's flat-rate pricing model.

Before restarting semaglutide or any weight loss medication postpartum, schedule a consultation with your primary care physician or an obesity medicine specialist to ensure you are medically cleared and that the medication aligns with your health goals. The Precision Peptide Genetic Test offered by PlexusDx can identify how your unique genetic variants in peptide pathways influence your metabolic response—this personalized insight may inform whether semaglutide or an alternative GLP-1 therapy is the best fit for your body.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I take semaglutide if I'm trying to become pregnant?

No, medical guidelines recommend stopping semaglutide at least two months before attempting conception. Animal studies have shown fetal abnormalities at higher doses, and human pregnancy data is insufficient. Work with your obstetrician to establish a safe timeline and alternative weight management strategies.

What should I do if I took semaglutide and then found out I was pregnant?

Stop taking the medication immediately and contact your obstetrician and pharmacist. One or two doses during early pregnancy are unlikely to cause harm based on available data, but your healthcare team should monitor your pregnancy closely. Do not resume semaglutide without explicit approval from your doctor.

Is semaglutide safe during breastfeeding?

Semaglutide passes into breast milk in animal studies, and human data is limited. Most healthcare providers recommend avoiding semaglutide while breastfeeding. Discuss timing with your obstetrical care team once you have decided to stop breastfeeding.

When can I restart semaglutide after pregnancy and breastfeeding?

After breastfeeding is complete and your healthcare provider has cleared you medically, semaglutide can be reintroduced. PlexusDx Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with no insurance required. Your doctor will assess your postpartum recovery and metabolic health before recommending restart.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

Yes. PlexusDx's Precision Peptide Genetic Test analyzes 14 pathways and 150+ genetic insights, including key variants like GLP1R rs6923761 that influence your response to GLP-1 medications. This $298 test personalizes your therapy plan and may inform whether semaglutide or an alternative like tirzepatide is optimal for your postpartum goals.

Related Reading

• Genetic Testing 101 What You Need To Know Before Getting Tested
• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.